The Context: In multiple sclerosis (MS), brain cells degenerate and malfunction, leaving patients with symptoms such as numbness, weakness, vision loss, tremor, fatigue, and cognitive impairment....
“We had the foundational tools we needed to move our research from academia to biotech,” remarked NYSCF – Robertson Investigator Alumnus Dr. Paul Tesar. “We had...
The Context: In multiple sclerosis, the immune system attacks myelin (the fatty substance that surrounds neurons and helps them send signals). Currently, there are no...
What They Did: Researchers at the National Institutes of Health (NIH) and Montana State University along with NYSCF Senior Principal Investigator Dr. Valentina Fossati examined cerebrospinal...
The National Stem Cell Foundation (NSCF), Summit for Stem Cell Foundation, The New York Stem Cell Foundation (NYSCF) Research Institute, and Space Tango today announced a...
Protocol adds a new cell type enabling myelination in human ‘mini-brains’ for laboratory research New York, NY (July 25, 2018) – In a collaborative study between...
Recently, NYSCF Research Institute Senior Investigator Valentina Fossati, PhD, was featured in an article from Neuro Central about the current state of multiple sclerosis (MS) research...
Your body is full of immune cells that fight off infection and illness. You’ve probably heard of a few of them: white blood cells, B cells,...
NYSCF – Robertson Stem Cell Investigator Alumnus and NYSCF – Robertson Stem Cell Prize recipient Dr. Marius Wernig of Stanford University published exciting results showing that nerve...
In a collaborative tour de force, five female principal investigators, including NYSCF’s own Dr. Valentina Fossati, are uncovering the cellular mechanisms behind multiple sclerosis (MS). Over...
NYSCF Chief of Staff David McKeon appeared on the Dr. Oz Show investigation “Exposing Experimental Stem Cell Treatments.” The segment highlighted the dangers of unproven stem...
The National Stem Cell Foundation (NSCF) and the NYSCF Research Institute announced that a grant from NSCF will be used to fund NYSCF research on cell...
NYSCF Principal Investigator Dr. Valentina Fossati shared how stem cell technology has revolutionized multiple sclerosis research during the session on remyelination at the Multiple Sclerosis Meeting...
NYSCF Principal Investigator Dr. Valentina Fossati and a team of NYSCF Research Institute scientists continued to unravel the mysteries of multiple sclerosis with her latest paper...
NYSCF spoke with Dr. Valentina Fossati who leads NYSCF’s multiple sclerosis research on the future of MS treatments and how stem cells have changed the field...
NYSCF Principal Investigator Dr. Valentina Fossati and NYSCF – Druckenmiller Postdoctoral Fellow Dr. Panagiotis Douvaras have improved a method for deriving oligodendrocyte progenitor cells – the types...
NYSCF – Robertson Stem Cell Investigator Dr. Paul Tesar, Case Western Reserve School of Medicine, and a team of scientists discovered that two drugs, one used...
For the first time, NYSCF scientists generated induced pluripotent stem (iPS) cells lines from skin samples of patients with primary progressive multiple sclerosis and further, they...
NYSCF announced that Dr. Marius Wernig, of Stanford University, is the recipient of the NYSCF – Robertson Stem Cell Prize. Dr. Wernig and his team discovered...
Neurology Today featured NYSCF – Helmsley Investigator Dr. Valentina Fossati’s latest research on multiple sclerosis in a larger story about Dr. Fossati and her personal commitment...
In conjunction with the Alzheimer’s Disease Resource Center (ADRC), NYSCF presented their latest Alzheimer’s research at the Jewish Center of the Hamptons in East Hampton. Presentations...
NYSCF welcomed the 2014 class of NYSCF – Druckenmiller Postdoctoral Fellows at a reception at the Asia Society. These seven exceptional scientists work in stem cell...
A team of scientists led by the NYSCF Research Institute’s Dr. Dieter Egli report the first ever patient-specific, diploid (i.e. with two sets of chromosomes, the...
NYSCF – Robertson Stem Cell Investigator Dr. Paola Arlotta, of Harvard University, has made an exciting breakthough and paradigm shift in the basic understanding of neuroanatomy....
In an exciting new development, the Food and Drug Administration (FDA) has approved a new stem cell-derived treatment for a phase I clinical trial in the...
